These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 11550308

  • 21. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
    Zhou XP, Sanson M, Hoang-Xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre JY, Thomas G, Hamelin R.
    Ann Neurol; 1999 Dec; 46(6):913-6. PubMed ID: 10589545
    [Abstract] [Full Text] [Related]

  • 22. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 23. Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.
    Ushio Y, Tada K, Shiraishi S, Kamiryo T, Shinojima N, Kochi M, Saya H.
    Front Biosci; 2003 May 01; 8():e281-8. PubMed ID: 12700122
    [Abstract] [Full Text] [Related]

  • 24. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 25. Genetic alterations in pediatric high-grade astrocytomas.
    Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS.
    Hum Pathol; 1999 Nov 01; 30(11):1284-90. PubMed ID: 10571506
    [Abstract] [Full Text] [Related]

  • 26. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY, Yuen ST, Chan TL, Chan AS, Ho JW, Kwan K, Fan YW, Hung KN, Chung LP, Wyllie AH.
    Oncogene; 2000 Aug 17; 19(35):4079-83. PubMed ID: 10962567
    [Abstract] [Full Text] [Related]

  • 27. Genetic alterations associated with the evolution and progression of astrocytic brain tumours.
    Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P.
    Virchows Arch; 1995 Aug 17; 427(2):113-8. PubMed ID: 7582239
    [Abstract] [Full Text] [Related]

  • 28. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1998 Jun 17; 95(6):559-64. PubMed ID: 9650746
    [Abstract] [Full Text] [Related]

  • 29. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
    Rathore A, Kamarajan P, Mathur M, Sinha S, Sarkar C.
    Pathol Oncol Res; 1999 Jun 17; 5(1):21-7. PubMed ID: 10079373
    [Abstract] [Full Text] [Related]

  • 30. [The molecular basis of glia-derived tumours of the brain. Part I].
    Nauman P, Czernicki Z.
    Neurol Neurochir Pol; 2002 Jun 17; 36(3):553-64. PubMed ID: 12185811
    [Abstract] [Full Text] [Related]

  • 31. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS, Lee MC, Kang SS, Kim JH, Jung S, Kim YJ, Lee JH, Ahn KY, Lee JS, Cheon JY.
    J Korean Med Sci; 2001 Aug 17; 16(4):481-8. PubMed ID: 11511795
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Genetic pathways to primary and secondary glioblastoma.
    Ohgaki H, Kleihues P.
    Am J Pathol; 2007 May 17; 170(5):1445-53. PubMed ID: 17456751
    [Abstract] [Full Text] [Related]

  • 34. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW.
    Brain Pathol; 2000 Apr 17; 10(2):249-59. PubMed ID: 10764044
    [Abstract] [Full Text] [Related]

  • 35. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
    Dong L, Pu PY, Wang H, Wang GX, Kang CS, Jiao DR.
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr 17; 35(4):232-6. PubMed ID: 16776982
    [Abstract] [Full Text] [Related]

  • 36. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 01; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.